Clinical Trial

CyberKnife Radiosurgery for Localized Prostatic Carcinoma

Study Description

CyberKnife Radiosurgery for Localized Prostatic Carcinoma

Virtual high dose rate (HDR) CyberKnife (CK) prostate treatment has comparable morbidity and efficacy compared with actual prostate HDR treatment, but does it without the catheters and hospital admission. As such, it is a more "patient friendly" treatment method compared with actual prostate HDR brachytherapy as currently practiced. Related, as has previously been reported with actual prostate HDR treatment, Virtual HDR CyberKnife prostate treatment should have a high efficacy but with lower acute and chronic morbidity compared with other local prostate cancer treatment methods such as permanent seed prostate brachytherapy.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Radiation - CyberKnife Radiosurgery

High Dose 3800 cGy/4 fractions

Radiation - CyberKnife Radiosurgery

Moderate Dose 3400 cGy/5 fractions

Additional Information

Official Study Title

Virtual HDR CyberKnife Radiosurgery for Localized Prostatic Carcinoma: A Phase II Study

Clinical Trial ID

NCT01045148

ParticipAid ID

0dNxza